1. Novo Nordisk
2. AstraZeneca plc
3. Biocon
4. Sanofi
5. Eli Lilly
6. Johnson & Johnson
7. Bristol Myers Squibb Co.
8. Novartis AG
Published | Pages | Publisher | Report code |
---|---|---|---|
Jul 2023 | 220 | Renub Research | ASDR-624046 |
1. Novo Nordisk
2. AstraZeneca plc
3. Biocon
4. Sanofi
5. Eli Lilly
6. Johnson & Johnson
7. Bristol Myers Squibb Co.
8. Novartis AG